Crescent Biopharma
CBIO
#6946
Rank
C$1.04 B
Marketcap
C$28.18
Share price
-2.01%
Change (1 day)
N/A
Change (1 year)

Crescent Biopharma (CBIO) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : C$26.86 Million

According to Crescent Biopharma's latest financial reports the company's total liabilities are C$26.86 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Crescent Biopharma - Total liabilities on balance sheet (from 2025 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31C$51.05 M-30.37%
2024-12-31C$73.32 M